Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modification of engineered influenza hemagglutinin polypeptides

Modification of engineered influenza hemagglutinin polypeptides

US Patent 11116832 · Granted Sep 14, 2021

Estimated economic value: $17,739,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered influenza antigenic polypeptides and immunogenic compositions thereof2025
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2025
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2024
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2024
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2024
Modification of engineered influenza hemagglutinin polypeptides2024
Modification of engineered influenza hemagglutinin polypeptides2024
Modification of engineered influenza hemagglutinin polypeptides2024
Methods of optimizing nucleotide sequences encoding engineered influenza protein2023
Methods of generating broadly protective vaccine compositions comprising hemaggl2023
Methods of generating broadly protective vaccine compositions comprising hemaggl2023
Methods of generating broadly protective vaccine compositions comprising hemaggl2023